BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29807272)

  • 21. [Expression and Clinical Significance of MicroRNA-195 in Patients with Diffuse Large B Cell Lymphoma].
    Liu RD; Zhuang W; Qi JD; Li CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):160-164. PubMed ID: 32027270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center.
    Li X; Xu-Monette ZY; Yi S; Dabaja BS; Manyam GC; Westin J; Fowler N; Miranda RN; Zhang M; Ferry JA; Medeiros LJ; Harris NL; Young KH
    Am J Surg Pathol; 2017 Oct; 41(10):1309-1321. PubMed ID: 28817403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation of MiR-34a Expression in Diffuse Large B Cell Lymphoma with Clinical Prognosis].
    Liu YP; Hu H; Xu F; Wen JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):455-459. PubMed ID: 28446292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
    Beheshti A; Stevenson K; Vanderburg C; Ravi D; McDonald JT; Christie AL; Shigemori K; Jester H; Weinstock DM; Evens AM
    Sci Rep; 2019 Nov; 9(1):17161. PubMed ID: 31748664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
    Lawrie CH; Chi J; Taylor S; Tramonti D; Ballabio E; Palazzo S; Saunders NJ; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS
    J Cell Mol Med; 2009 Jul; 13(7):1248-60. PubMed ID: 19413891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
    Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
    Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
    Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA
    Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
    Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
    Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of MiRNA-21 in diffuse large B cell lymphoma and its significance].
    Song GQ; Gu L; He BS; Pan YQ; Wang SK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1603-9. PubMed ID: 25543482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
    Hu LY; Xu XL; Rao HL; Chen J; Lai RC; Huang HQ; Jiang WQ; Lin TY; Xia ZJ; Cai QQ
    Chin J Cancer; 2017 Dec; 36(1):94. PubMed ID: 29246182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
    Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
    Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.
    Högfeldt T; Johnsson P; Grandér D; Bahnassy AA; Porwit A; Eid S; Österborg A; Zekri AR; Lundahl J; Khaled MH; Mellstedt H; Moshfegh A
    Leuk Lymphoma; 2014 May; 55(5):1158-65. PubMed ID: 23841503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
    Lawrie CH; Gal S; Dunlop HM; Pushkaran B; Liggins AP; Pulford K; Banham AH; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS; Harris AL
    Br J Haematol; 2008 May; 141(5):672-5. PubMed ID: 18318758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
    Yao XX; Wang JF; Wang YH; Gao N
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma.
    Berglund M; Hedström G; Amini RM; Enblad G; Thunberg U
    Oncol Rep; 2013 Feb; 29(2):720-4. PubMed ID: 23232598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-21 predicts the prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma.
    Ji Q; Jiang T; Su J; Zhang S; Li C; Yang X; Wu X; Yao J; Yuan D; Wang J
    Acta Biochim Pol; 2022 Jun; 69(2):379-385. PubMed ID: 35691029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
    Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
    Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
    Sun R; Zheng Z; Wang L; Cheng S; Shi Q; Qu B; Fu D; Leboeuf C; Zhao Y; Ye J; Janin A; Zhao WL
    Mol Oncol; 2021 Jan; 15(1):246-261. PubMed ID: 33107145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
    Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
    Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.